Breaking News

Citigroup Profit Falls 96% on Costs to End Mortgage-Bond Probe
Tweet TWEET

Hagens Berman Sobol Shapiro LLP Lawsuit: Fresenius Medical Care and DaVita Healthcare Partners Liable for GranuFlo and

  Hagens Berman Sobol Shapiro LLP Lawsuit: Fresenius Medical Care and DaVita
        Healthcare Partners Liable for GranuFlo and NaturaLyte Deaths

PR Newswire

SEATTLE, March 6, 2013

SEATTLE, March 6, 2013 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a law
firm with experience prosecuting cases against healthcare providers and the
pharmaceutical industry, today filed two lawsuits in Federal Court in Colorado
alleging that DaVita Healthcare Partners, Inc.'s (NYSE: DVA) ("DaVita")
actions led to the deaths of two dialysis patients. The lawsuits further
allege that the problems that caused those deaths have impacted thousands of
dialysis patients across the country, and seek class action status.

The suits claim that DaVita – one of the nation's largest providers of
dialysis services – failed to recognize that part of the treatment it used in
dialysis was causing dangerously high levels of bicarbonates in the patients,
which the suit claims caused the deaths of the two patients cited in the
suits, and potentially many other unreported deaths and injuries, including
cardiac arrest and stroke.

Hagens Berman has also filed suits against Fresenius Medical Care North
America (FMC) ("Fresenius"), the company who manufactured and distributed the
two products. According to those lawsuits, an internal memo dated Nov. 4,
2011, reveals that Fresenius knew of the dangers associated with GranuFlo and
NaturaLyte, two dialysis products, far in advance of informing the FDA.
Moreover, the complaints allege that Fresenius made adjustments at its own
clinics to reduce the impact on patients, showing it was aware of the problem.

The suits seek to represent patients who suffered cardiac arrest, stroke,
respiratory issues or a litany of other health problems linked to the use of
GranuFlo and NaturaLyte, both of which were recalled by the FDA on March 29,
2012.

Patients, former patients or their surviving families who believe they
suffered from cardiac, stroke or other adverse events associated with the
products are encouraged to contact Hagens Berman attorneys. You can reach an
attorney by calling 888-381-2889 or by emailing Fresenius@hbsslaw.com.

According to Steve Berman, managing partner of Hagens Berman, DaVita shares
the blame, even though Fresenius manufactured and distributed the products.
"Even before the FDA stepped in, our medical experts all conclude that DaVita
should have recognized that its patients using the two products showed wild
swings in their bicarbonate levels, a clear indication that they were at a
much higher risk of cardiac arrest."

Berman also noted that DaVita failed to recognize trends in the number of
complications and deaths after dialysis treatments. "Even had the company
overlooked the trends relating to bicarbonate levels, we would expect that the
high number of complications and deaths would have alerted them that something
was amiss."

The class-action complaints cite two patients who died of cardiac arrest while
receiving treatment from DaVita. Stella Nunes, a California resident, suffered
a fatal heart attack on Dec. 26, 2012, while receiving dialysis treatment.
Jean Thornton, a Wisconsin resident, suffered a fatal heart attack shortly
after returning home from treatment at a DaVita clinic in Nov. 2011, according
to the lawsuit. The lawsuit claims that these deaths could have been prevented
had DaVita properly monitored the bicarbonate levels of its patients and
tracked deaths and complications associated with its use of GranuFlo and
NaturaLyte.

The lawsuits claim that DaVita is guilty of negligence for failing to protect
its patients from the products.

DaVita owns and operates 1,954 outpatient dialysis centers in 44 states
throughout the United States.

More information is available at
http://www.hbsslaw.com/cases-and-investigations/Fresenius

About Hagens Berman
Seattle-based Hagens Berman Sobol Shapiro LLP is a national plaintiff-focused
law firm with offices in ten cities. Founded in 1993, we represent plaintiffs
in class actions and multi-state, large-scale litigation that seek to protect
the rights of investors, consumers, workers, whistleblowers and others. More
information about the firm is available at www.hbsslaw.com

Media Contacts

Firmani + Associates Inc.
Mark Firmani, 206-443-9357
mark@firmani.com

SOURCE Hagens Berman Sobol Shapiro LLP

Website: http://www.hbsslaw.com